Identification of a human glioma antigen, SOX6, recognized by patients' sera

Ryo Ueda, Yukihiko Iizuka, Kazunari Yoshida, Takeshi Kawase, Yutaka Kawakami, Masahiro Toda

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

To identify tumor antigens for glioma, a human testis cDNA library was screened by serological identification of antigens by recombinant expression cloning with sera from glioma patients. In this screening, the most frequently isolated antigen was SOX6, an Sry-related high-mobility group (HMG) box-containing gene. SOX6 is a transcriptional factor that is specifically expressed in the developing central nervous system and in the early stages of chondrogenesis in mouse embryos. IgG antibodies against SOX6 were detected in sera from 12 of 36 glioma patients (33.3%), 0 of 14 patients with other brain disease (0%), and one of 54 other cancer patients (1.9%). In sera from 37 healthy individuals, no IgG responses against SOX6 were detected, except in an elderly female. Furthermore, Western blot and ELISA analyses with sera from glioma patients revealed that the DNA-binding domain, the HMG box of SOX6, might be a dominant epitope of IgGs against SOX6. RT-PCR and Northern blot analysis revealed that the SOX6 gene was more highly expressed in glioma tissues than in normal adult tissues, except testis. Western blot analysis with an anti-SOX6 antibody demonstrated that the SOX6 protein was expressed in glioma tissues, but not in normal adult brain tissue. Immunohistochemical analysis with the anti-SOX6 antibody showed that all the glioma tissues analysed expressed SOX6 in tumor cells, but only a few SOX6-positive cells were detected in non-neoplastic tissues from the cerebral cortex. In summary, these results indicate that the developmentally regulated transcription factor SOX6 is aberrantly expressed in glioma and specifically recognized by IgGs from glioma patients' sera.

Original languageEnglish
Pages (from-to)1420-1427
Number of pages8
JournalOncogene
Volume23
Issue number7
DOIs
Publication statusPublished - 2004 Feb 19

Fingerprint

Forensic Anthropology
Glioma
Antigens
Serum
SOXD Transcription Factors
HMG-Box Domains
Testis
Anti-Idiotypic Antibodies
Immunoglobulin G
Western Blotting
Chondrogenesis
Brain Diseases
Neoplasm Antigens
Gene Library
Northern Blotting
Cerebral Cortex
Genes
Organism Cloning
Epitopes
Neoplasms

Keywords

  • CT antigen
  • Glioma
  • IgG response
  • SEREX
  • SOX6
  • Tumor antigen

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Identification of a human glioma antigen, SOX6, recognized by patients' sera. / Ueda, Ryo; Iizuka, Yukihiko; Yoshida, Kazunari; Kawase, Takeshi; Kawakami, Yutaka; Toda, Masahiro.

In: Oncogene, Vol. 23, No. 7, 19.02.2004, p. 1420-1427.

Research output: Contribution to journalArticle

Ueda, Ryo ; Iizuka, Yukihiko ; Yoshida, Kazunari ; Kawase, Takeshi ; Kawakami, Yutaka ; Toda, Masahiro. / Identification of a human glioma antigen, SOX6, recognized by patients' sera. In: Oncogene. 2004 ; Vol. 23, No. 7. pp. 1420-1427.
@article{f0cf5b4b75d3438a9e452da9726aa27c,
title = "Identification of a human glioma antigen, SOX6, recognized by patients' sera",
abstract = "To identify tumor antigens for glioma, a human testis cDNA library was screened by serological identification of antigens by recombinant expression cloning with sera from glioma patients. In this screening, the most frequently isolated antigen was SOX6, an Sry-related high-mobility group (HMG) box-containing gene. SOX6 is a transcriptional factor that is specifically expressed in the developing central nervous system and in the early stages of chondrogenesis in mouse embryos. IgG antibodies against SOX6 were detected in sera from 12 of 36 glioma patients (33.3{\%}), 0 of 14 patients with other brain disease (0{\%}), and one of 54 other cancer patients (1.9{\%}). In sera from 37 healthy individuals, no IgG responses against SOX6 were detected, except in an elderly female. Furthermore, Western blot and ELISA analyses with sera from glioma patients revealed that the DNA-binding domain, the HMG box of SOX6, might be a dominant epitope of IgGs against SOX6. RT-PCR and Northern blot analysis revealed that the SOX6 gene was more highly expressed in glioma tissues than in normal adult tissues, except testis. Western blot analysis with an anti-SOX6 antibody demonstrated that the SOX6 protein was expressed in glioma tissues, but not in normal adult brain tissue. Immunohistochemical analysis with the anti-SOX6 antibody showed that all the glioma tissues analysed expressed SOX6 in tumor cells, but only a few SOX6-positive cells were detected in non-neoplastic tissues from the cerebral cortex. In summary, these results indicate that the developmentally regulated transcription factor SOX6 is aberrantly expressed in glioma and specifically recognized by IgGs from glioma patients' sera.",
keywords = "CT antigen, Glioma, IgG response, SEREX, SOX6, Tumor antigen",
author = "Ryo Ueda and Yukihiko Iizuka and Kazunari Yoshida and Takeshi Kawase and Yutaka Kawakami and Masahiro Toda",
year = "2004",
month = "2",
day = "19",
doi = "10.1038/sj.onc.1207252",
language = "English",
volume = "23",
pages = "1420--1427",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Identification of a human glioma antigen, SOX6, recognized by patients' sera

AU - Ueda, Ryo

AU - Iizuka, Yukihiko

AU - Yoshida, Kazunari

AU - Kawase, Takeshi

AU - Kawakami, Yutaka

AU - Toda, Masahiro

PY - 2004/2/19

Y1 - 2004/2/19

N2 - To identify tumor antigens for glioma, a human testis cDNA library was screened by serological identification of antigens by recombinant expression cloning with sera from glioma patients. In this screening, the most frequently isolated antigen was SOX6, an Sry-related high-mobility group (HMG) box-containing gene. SOX6 is a transcriptional factor that is specifically expressed in the developing central nervous system and in the early stages of chondrogenesis in mouse embryos. IgG antibodies against SOX6 were detected in sera from 12 of 36 glioma patients (33.3%), 0 of 14 patients with other brain disease (0%), and one of 54 other cancer patients (1.9%). In sera from 37 healthy individuals, no IgG responses against SOX6 were detected, except in an elderly female. Furthermore, Western blot and ELISA analyses with sera from glioma patients revealed that the DNA-binding domain, the HMG box of SOX6, might be a dominant epitope of IgGs against SOX6. RT-PCR and Northern blot analysis revealed that the SOX6 gene was more highly expressed in glioma tissues than in normal adult tissues, except testis. Western blot analysis with an anti-SOX6 antibody demonstrated that the SOX6 protein was expressed in glioma tissues, but not in normal adult brain tissue. Immunohistochemical analysis with the anti-SOX6 antibody showed that all the glioma tissues analysed expressed SOX6 in tumor cells, but only a few SOX6-positive cells were detected in non-neoplastic tissues from the cerebral cortex. In summary, these results indicate that the developmentally regulated transcription factor SOX6 is aberrantly expressed in glioma and specifically recognized by IgGs from glioma patients' sera.

AB - To identify tumor antigens for glioma, a human testis cDNA library was screened by serological identification of antigens by recombinant expression cloning with sera from glioma patients. In this screening, the most frequently isolated antigen was SOX6, an Sry-related high-mobility group (HMG) box-containing gene. SOX6 is a transcriptional factor that is specifically expressed in the developing central nervous system and in the early stages of chondrogenesis in mouse embryos. IgG antibodies against SOX6 were detected in sera from 12 of 36 glioma patients (33.3%), 0 of 14 patients with other brain disease (0%), and one of 54 other cancer patients (1.9%). In sera from 37 healthy individuals, no IgG responses against SOX6 were detected, except in an elderly female. Furthermore, Western blot and ELISA analyses with sera from glioma patients revealed that the DNA-binding domain, the HMG box of SOX6, might be a dominant epitope of IgGs against SOX6. RT-PCR and Northern blot analysis revealed that the SOX6 gene was more highly expressed in glioma tissues than in normal adult tissues, except testis. Western blot analysis with an anti-SOX6 antibody demonstrated that the SOX6 protein was expressed in glioma tissues, but not in normal adult brain tissue. Immunohistochemical analysis with the anti-SOX6 antibody showed that all the glioma tissues analysed expressed SOX6 in tumor cells, but only a few SOX6-positive cells were detected in non-neoplastic tissues from the cerebral cortex. In summary, these results indicate that the developmentally regulated transcription factor SOX6 is aberrantly expressed in glioma and specifically recognized by IgGs from glioma patients' sera.

KW - CT antigen

KW - Glioma

KW - IgG response

KW - SEREX

KW - SOX6

KW - Tumor antigen

UR - http://www.scopus.com/inward/record.url?scp=1442357201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442357201&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207252

DO - 10.1038/sj.onc.1207252

M3 - Article

VL - 23

SP - 1420

EP - 1427

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 7

ER -